Results 81 to 90 of about 19,736 (150)

Prognostic Impact of Concomitant Genomic Alterations in FGFR2‐Positive Cholangiocarcinoma Treated With Pemigatinib

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background & Aims Anti‐FGFR therapies changed the treatment landscape for patients with previously treated, advanced, or metastatic cholangiocarcinoma (CCA) harbouring FGFR2 fusions/rearrangements. However, primary resistance to FGFR inhibitors remains a key challenge. In the present real‐world study, we aimed to evaluate the prognostic impact
Carolina Liguori, Riccardo Giampieri, Blandine Delaunay, Giada Pinterpe, Adelaide Mazzocca, Antoine Hollebecque, Jean Frederic Blanc, Mohamed Bouattour, Eric Assenat, Meher Ben Abdelghani, Matthieu Sarabi, Monica Niger, Caterina Vivaldi, Mario Mandalà, Andrea Palloni, Maria Bensi, Silvio Ken Garattini, David Tougeron, Pierre Combe, Massimiliano Salati, Margherita Rimini, Andrea Casadei‐Gardini, Chiara Alessandra Cella, Marco Tucci, Anna Diana, Elena Mori, Raffaella Longarini, Pascal Artru, Gael Roth, Ludovic Evesque, Agathe Vienne, Anthony Turpin, Sandrine Hiret, Vincent Bourgeois, Camille Herve, Rodolphe Paulon, Marion Stacoffe, David Malka, Matthieu Delaye, Julien Edeline, Astrid Lievre, Rosine Guimbaud, Rita Balsano, Nadim Fares, Rossana Berardi, Alessandro Parisi   +45 more
wiley   +1 more source

Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies

American Journal of Ophthalmology Case Reports
Purpose: To report two new cases and summarize one case of uveal melanoma following treatment of hematologic malignancies with Bruton's tyrosine kinase inhibitors.
Tara Murty, Jonathan H. Lin, Prithvi Mruthyunjaya   +2 more
doaj   +1 more source

A Multistep Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal Melanoma. [PDF]

Cancer Res
Xu X, Liu X, Jarajapu V, Neelature Sriramareddy S, Konecny F, Posorske B, Dollar JJ, Liu X, Jasani N, Wang K, Mecozzi N, Soto-Vargas Z, Ochoa-Rios SL, Murikipudi H, Phan N, Chadourne M, Kuznetsoff JN, Sinard J, Bennett RL, Licht JD, Smalley KSM, Harbour JW, Yu X, Karreth FA.   +23 more
europepmc   +1 more source

Uveal Melanoma Ground Truth Labeling in Machine Learning. [PDF]

Cancers (Basel)
Kao E, Ganesh S, Chadwick WF, Alahmadi R, Yao X, Heiferman MJ.   +5 more
europepmc   +1 more source

Author Correction: Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes

Nature Communications
André Bortolini Silveira, Alexandre Houy, Olivier Ganier, Begüm Özemek, Sandra Vanhuele, Anne Vincent-Salomon, Nathalie Cassoux, Pascale Mariani, Gaelle Pierron, Serge Leyvraz, Damian Rieke, Alberto Picca, Franck Bielle, Marie-Laure Yaspo, Manuel Rodrigues, Marc-Henri Stern   +15 more
doaj   +1 more source

A Framework for Standardized Manual Segmentation and Measurement of Uveal Melanoma on Ultrasound. [PDF]

Ophthalmol Sci
Chadwick WF, Ganesh S, Dadzie AK, Lokesh Y, Alahmadi R, Yao X, Heiferman MJ.   +6 more
europepmc   +1 more source

The complement system contributes to the immunosuppressive microenvironment of uveal melanoma. [PDF]

J Transl Med
Zherka I, Kalirai H, Majorova D, Coupland SE, Olcina MM.   +4 more
europepmc   +1 more source

Current Treatment Standards for Metastatic Uveal Melanoma. [PDF]

Cancers (Basel)
Rogala P, Czarnecka AM, Dudzisz-Śledź M, Dawidowska A, Piwowarek KJ, Rutkowski P.   +5 more
europepmc   +1 more source

Pegargiminase Suppresses the Fanconi Anemia Pathway and Promotes Melphalan-Induced DNA Double-Strand Breaks in Uveal Melanoma. [PDF]

Pigment Cell Melanoma Res
Pavlyk I, Field G, Young M, Carpentier J, Szlosarek EA, O'Keeffe-Brown MR, Crook T, Syed N, Bomalaski JS, Chan PY, Szlosarek PW.   +10 more
europepmc   +1 more source

Uveal Melanoma: Changing Paradigms of Treatment. [PDF]

Ocul Oncol Pathol
Piperno-Neumann S.
europepmc   +1 more source